Investigational Drug Details
| Drug ID: | D014 |
| Drug Name: | ARI-3037MO |
| Synonyms: | -- |
| Type: | Biological drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | 2166482-73-9 |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | GPR109A receptor agonist; GPR109B receptor agonist; Nicotinic acid analog |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 on-going (NCT02574325) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0287 | NCT02574325 | Phase 2 | Unknown status | No Results Available | October 2015 | August 8, 2016 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|